Aplio i900, Aplio i800 and Aplio i700 Software V9.0 Diagnostic Ultrasound System
Canon Medical Systems Corporation
Aplio i900, i800, and i700 software V9.0 are mobile diagnostic ultrasound systems for multi-region imaging. K252074 adds deep-learning 3rd Harmonic Imaging for abdominal images; with specified endoscopic transducers, the Aplio i800/E3 also supports imaging of the upper gastrointestinal tract, surrounding organs, airways, tracheobronchial tree, and esophagus.
Evidence status: each field shows source quality, applicability, and review date. Research pending, information not established in reviewed sources, and vendor documentation pending are distinct outcomes.
Clinical fit
What this tool is for
Start with the authorized purpose, then verify how it fits your service line and reading workflow.
Exact purpose
Aplio i900, i800, and i700 software V9.0 are mobile diagnostic ultrasound systems for multi-region imaging. K252074 adds deep-learning 3rd Harmonic Imaging for abdominal images; with specified endoscopic transducers, the Aplio i800/E3 also supports imaging of the upper gastrointestinal tract, surrounding organs, airways, tracheobronchial tree, and esophagus.
FDA source Exact FDA submission Checked 2026-09-02
Supports standard diagnostic ultrasound acquisition and review. V9.0 adds deep-learning 3rd Harmonic Imaging for abdominal image filtering, SMI Angio Mode for separating adjacent blood flows, Precision+ Fine Processing for border depiction, Auto Tune pre-scanning for shear-wave acquisition, and expanded endoscopic ultrasound support on the Aplio i800/E3.
FDA source Exact FDA submission Checked 2026-09-02
Ultrasound images and Doppler or elastography data acquired with compatible Aplio i900, i800, or i700 probes operating at approximately 2 to 33 MHz; 3rd Harmonic Imaging processes abdominal images, while specified endoscopic workflows use GF-UCT180 or BF-UC190F transducers on the Aplio i800/E3.
FDA source Exact FDA submission Checked 2026-09-02
The 3rd Harmonic Imaging evaluation used images from 30 U.S. patients at one site and assessed image quality rather than diagnostic accuracy or patient outcomes. Endoscopic indications require the specified Aplio i800/E3 and transducer configurations. Feature availability depends on the installed model, probes, and licensed options.
FDA source Exact FDA submission Checked 2026-09-02
The FDA listing establishes the regulatory identity. It does not by itself establish local workflow fit, pricing, security, or performance in your environment.
FDA submission
K252074
FDA source Exact FDA submission Checked 2026-08-31
Use these fields to structure a vendor demo, security review, and implementation estimate.
Integration
The system is an on-premises ultrasound platform with site-network image exchange. Canon's current interoperability page lists an IHE integration statement for Aplio i700, i800, and i900 software V6.0 or later, covering V9.0.
Public source Exact product version Checked 2026-09-02
Confirm the installed IHE statement, DICOM services, endoscopic-video workflow, network routing, and downstream object support.
On-premises mobile Aplio i900, i800, or i700 ultrasound console running software V9.0 on Windows 11 LTSC; endoscopic imaging requires the specified Aplio i800/E3 configuration and transducer.
FDA source Exact FDA submission Checked 2026-09-02
Vendor confirmation Exact FDA submission Checked 2026-08-13
FDA authorization does not establish the current commercial security posture. Request data-flow diagrams, hosting and retention details, access controls, audit logging, attestations, and incident-response documentation.
Training and support
Vendor documentation pending
Vendor confirmation Exact FDA submission Checked 2026-08-13
Training, onboarding, competency, and support commitments are commercial implementation details that require current vendor documentation.
Monitoring and change control
The 3rd Harmonic Imaging algorithm was locked after development and the FDA summary states that no postmarket continuous-learning capability is deployed on the device.
FDA source Exact FDA submission Checked 2026-09-02
A locked model does not replace local acceptance testing, image-quality monitoring, update review, or incident escalation.
Adds deep-learning 3rd Harmonic Imaging, SMI Angio Mode, Precision+ Fine Processing Mode, and Auto Tune for shear-wave elasticity and dispersion workflows.
exact submission · checked 2026-09-02
Confirm licensed options, compatible probes and presets, user controls, processing behavior, and output objects.
The Aplio i800 TUS-AI800/E3 supports the GF-UCT180 and BF-UC190F endoscopic transducers for the specific gastrointestinal and airway indications in the FDA labeling.
exact submission · checked 2026-09-02
Verify console variant, transducer and endoscope compatibility, reprocessing workflow, accessories, and staff training.
The FDA summary identifies Windows 11 LTSC as the operating system incorporated in the V9.0 devices, replacing Windows 10 LTSC in the predicate configuration.
exact submission · checked 2026-09-02
Confirm the exact LTSC release, patching responsibility, endpoint controls, service-access model, and vendor support lifecycle.
Metrics are shown only when they are tied to a source, endpoint, population, and tested product version.
Evidence summary
FDA-reviewed support includes a manufacturer-sponsored, single-site, blinded image-quality study for 3rd Harmonic Imaging plus phantom and small-volunteer studies for other V9.0 features. The submission does not report diagnostic-accuracy or patient-outcome endpoints.
FDA source Exact FDA submission Checked 2026-09-02
Needs research Exact FDA submission Checked 2026-08-31
This field has not been curated yet.
Reported specificity
Research pending
Needs research Exact FDA submission Checked 2026-08-31
This field has not been curated yet.
No contextualized exact-version metric has completed evidence review. Regulatory-document values, when available, are shown above with their limitations.
K252074 3rd Harmonic Imaging blinded observer study
Manufacturer-sponsored blinded image-quality comparison of 3rd Harmonic Imaging with conventional second-harmonic imaging using three U.S. board-certified radiologists and a five-point ordinal scale · At least 294 abdominal images from 30 patients at one U.S. site; ages 23 to 89 years, approximately balanced sex, BMI 18.5 to 36.3 kg/m2, and representative abdominal structures and focal pathologies
exact submission · Tested version: K252074 3rd Harmonic Imaging on Aplio i900, i800, and i700 software V9.0 · n=30 · 1 site · Sponsor or vendor study
K252074
The locked validation dataset was independent of training data. Scores were above the neutral midpoint for three image-quality domains, but effect sizes, diagnostic accuracy, and patient outcomes were not reported.
Manufacturer phantom and volunteer-image verification for SMI Angio Mode, Auto Tune, Precision+ Fine Processing, and 3rd Harmonic Imaging · Phantom data, images from three volunteers for SMI Angio Mode, thyroid and liver images from three volunteers for Auto Tune, representative clinical images for Precision+, and five abdominal phantoms for 3rd Harmonic Imaging
exact submission · Tested version: Aplio i900, i800, and i700 software V9.0 · Sponsor or vendor study
K252074
Regulatory feature verification; it does not establish diagnostic accuracy, comparative clinical outcomes, or local-site performance.
These are common procurement questions; unknown values remain visible until a source supports them.
Pricing and total cost
Vendor documentation pending
Vendor confirmation Exact FDA submission Checked 2026-08-13
FDA submission materials do not establish current commercial pricing. Request the pricing unit, term, minimum commitment, implementation fees, and included support from the vendor.
Reimbursement and coding
Research pending
Needs research Exact FDA submission Checked 2026-08-31
Determine whether any product-specific CPT/HCPCS pathway exists and separate it from billing for the underlying imaging service.
Safety and lifecycle
Postmarket record
Recall and adverse-event records are shown only after product matching. Adverse-event reports do not establish incidence or causality.
Postmarket safety review
Not established in reviewed sources
Reviewed sources checked Exact FDA submission Checked 2026-09-04
No native submission-identifier match was found in the checked openFDA radiology recall snapshot. Product-name, manufacturer, and adverse-event searches remain necessary; this does not establish that no recall or safety report exists.
Buyer worksheet
Open questions to take to the vendor
Verify security and privacy controls: FDA authorization does not establish the current commercial security posture. Request data-flow diagrams, hosting and retention details, access controls, audit logging, attestations, and incident-response documentation.
Verify training: Training, onboarding, competency, and support commitments are commercial implementation details that require current vendor documentation.
Verify pricing and total cost: FDA submission materials do not establish current commercial pricing. Request the pricing unit, term, minimum commitment, implementation fees, and included support from the vendor.
Verify reimbursement and coding relevance: Determine whether any product-specific CPT/HCPCS pathway exists and separate it from billing for the underlying imaging service.
Verify recalls and postmarket safety signals: No native submission-identifier match was found in the checked openFDA radiology recall snapshot. Product-name, manufacturer, and adverse-event searches remain necessary; this does not establish that no recall or safety report exists.
This audit distinguishes completed source review from fields that have not yet been researched.
Human reviewedStatus
2026-09-04Last searched
18Fields reviewed
7Source classes checked
0Unreviewed PubMed leads
0Unreviewed trial leads
0Unreviewed FDA recall leads
Recovered from the prior exact-submission extraction and normalized under the current provenance rules. The exact FDA summary and current Canon interoperability index were manually reviewed. The 3rd Harmonic Imaging evidence is manufacturer-sponsored and single-site; current security, training, pricing, reimbursement, and operational monitoring remain separate verification tasks. Automated exact-name discovery found 0 PubMed and 0 ClinicalTrials.gov candidate records. Candidates require human product and version matching; zero candidates is not evidence that no studies exist. Native FDA recall identifiers produced 0 postmarket candidate records; 0 have been reviewed (0 published, 0 rejected) and 0 remain unreviewed.
Candidate leads remain unpublished until a human confirms the exact product and tested version.
Source classes: fda ai list, fda decision summary, fda device recall, vendor interoperability, pubmed, clinical trials, openfda device recall
EPIQ and Affiniti diagnostic ultrasound systems provide the labeled abdominal, cardiac, fetal, pediatric, vascular, cephalic, gynecologic, musculoskeletal, small-organ, urologic,...
Ge Medical Systems Ultrasound and Primary Care Diagnostics
LOGIQ E10s is a general-purpose diagnostic ultrasound system supporting the labeled adult, pediatric, cardiac, vascular, abdominal, obstetric, small-organ, musculoskeletal,...
Ge Medical Systems Ultrasound and Primary Care Diagnostics
LOGIQ E10 is a general diagnostic ultrasound system for qualified users across fetal and obstetric, abdominal, gynecologic, pediatric, small-organ, breast, cardiac, vascular,...
GE Medical Systems Ultrasound and Primary care Diagnostics
Venue, Venue Go, Venue Fit, and Venue Sprint are general-purpose point-of-care ultrasound systems for trained users across broad adult, pediatric, and neonatal applications, with...